|Articles|January 15, 2002

BioPharm International

  • BioPharm International-01-01-2002
  • Volume 15
  • Issue 1

Inside Washington: Biotechnology in the Limelight, the Year Ahead

Author(s)Jill Wechsler

by Jill Wechsler Continued concerns about bioterrorism will shape legislative and regulatory initiatives affecting biotech manufactures.

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.